Effect of Ergocalciferol on β-Cell Function in New-Onset Type 1 Diabetes: A Secondary Analysis of a Randomized Clinical Trial

JAMA Netw Open. 2024 Mar 4;7(3):e241155. doi: 10.1001/jamanetworkopen.2024.1155.
No abstract available

Plain language summary

This secondary analysis of a randomized clinical trial evaluates the effectiveness of ergocalciferol vs placebo in youths with newly diagnosed type 1 diabetes.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Diabetes Mellitus, Type 1* / drug therapy
  • Ergocalciferols*
  • Humans

Substances

  • Ergocalciferols